Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells from ascites

: Murumagi A, Hirasawa A, Arjama M, Valimaki K, Yadav B, Tang J, Szwajda A, Turunen L, Mpindi JP, Pellinen T, Wennerberg K, Butzow R, Aittokallio T, Kallioniemi I

Publisher: AMER ASSOC CANCER RESEARCH

: 2015

Cancer Research

CANCER RESEARCH

: CANCER RES

: 75

: 2

: 0008-5472

DOI: https://doi.org/10.1158/1538-7445.AM2015-3746